オハイオにおける左室機能不全の臨床試験
オハイオ内の拠点で、左室機能不全に関する4件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Cincinnati Children's Hospital Medical Center ( Site 0034), Cincinnati
- Cleveland Clinic-Cleveland Clinic Chidren's ( Site 0022), Cleveland
被験者募集中第2/3相
29 Days – 17 Years · 全性別 · 2026/08/28更新 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital - Cardiology, Columbus
被験者募集中第3相
18歳以下 · 全性別 · 2026/06/29更新 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital - Cardiology, Columbus
被験者募集中第3相
6 Months – 17 Years · 全性別 · 2026/06/15更新 · NCT07188805The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/04/28更新 · NCT05427370ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。